Induction of rat hepatic cytochrome P450 enzymes by myristicin.
The effect of myristicin on the expression of liver cytochrome P450s and its mRNA levels was examined in rats. Treatment of rats with myristicin (i.p., 500 mumol/kg) caused 2-20 fold increases in liver P450 1A1/2, 2B1/2, and 2E1 enzyme activities relative to controls. Immunoblot analysis using anti-rat liver P450 1A, 2B, and 2E1 showed that the increases in each of P450 protein levels by myristicin were consistent with those in enzyme activity levels. When increased levels of P450 mRNA by myristicin were examined by Northern blot analysis, levels of mRNA of P450 1A1/2 and 2B1/2 also increased. However, the level of P4502E1 mRNA did not increase. The total amount of spectrally detectable P450, also increased about 1.5-fold following treatment of myristicin. These results demonstrate that myristicin is an inducer of rat liver P450 1A1/2, 2B1/2, and 2E1, and that the induction involves increases in mRNA levels except in the case of P4502E1.
Jeong
H G
HG
Department of Environmental Science, Chosun University, Kwangju, Korea.
Yun
C H
CH
D000081248:Allylbenzene Derivatives; D000818:Animals; D001593:Benzyl Compounds; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004148:Dioxolanes / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D015870:Gene Expression; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D011748:Pyrogallol / Q000031:analogs & derivatives; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
D000081248:Allylbenzene Derivatives; D001593:Benzyl Compounds; D004148:Dioxolanes; D007527:Isoenzymes; D012333:RNA, Messenger; D011748:Pyrogallol; C005246:myristicin; D003577:Cytochrome P-450 Enzyme System